Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pain

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpain.2013.05.010PMID 23850177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioid Shopping Behavior: How Often, How Soon, Which Drugs, and What Payment Method

  2013cited by this paper
• Street Prices of Prescription Opioids Diverted to the Illicit Market: Data from a National Surveillance Program

  2013cited by this paper
• Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.

  2013cited by this paper
• Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan.

  2012cited by this paper
• CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

  2012cited by this paper
• Assessing Opioid Shopping Behaviour

  2012cited by this paper
• Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system

  2012cited by this paper
• Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons

  2012cited by this paper
• Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure

  2012cited by this paper
• Assessment of the abuse of tapentadol immediate release: The first 24 months

  2012cited by this paper
• CDC grand rounds

  2012cited by this paper
• Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases

  2012cited by this paper
• Assessment of the abuse of tapentadol immediate release: the first 24 months.

  2012cited by this paper
• Doctor and Pharmacy Shopping for Controlled Substances

  2012cited by this paper
• Limiting the potential harms of high-dose opioid therapy: comment on "Opioid dose and drug-related mortality in patients with nonmalignant pain".

  2011cited by this paper
• Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment.

  2011cited by this paper
• Opioid dose and drug-related mortality in patients with nonmalignant pain.

  2011cited by this paper
• Effects of adjusting for instrumental variables on bias and precision of effect estimates.

  2011cited by this paper
• The painful truth: deaths and misuse of prescribed drugs

  2011cited by this paper
• Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

  2010cited by this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Original Research Article Post-marketing Surveillance of Methadone and Buprenorphine in the United States

  2010cited by this paper
• Matching methods for causal inference: A review and a look forward.

  2010cited by this paper
• Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study.

  2010cited by this paper
• Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally‐acting analgesics on the horizon?

  2010cited by this paper
• Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States

  2010cited by this paper
• Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

  2010cited by this paper
• Synaptic Mechanism for Functional Synergism between δ- and μ-Opioid Receptors

  2010cited by this paper
• High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

  2009cited by this paper
• Reward processing by the opioid system in the brain.

  2009cited by this paper
• Analytic models to identify patients at risk for prescription opioid abuse.

  2009cited by this paper
• Predicting Opioid Misuse by Chronic Pain Patients: A Systematic Review and Literature Synthesis

  2008cited by this paper
• (–)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties

  2007cited by this paper
• Opioid Prescriptions Soar

  2007cited by this paper
• Opioid prescriptions soar: increase in legitimate use as well as abuse.

  2007cited by this paper
• Large-Scale Bayesian Logistic Regression for Text Categorization

  2007cited by this paper
• Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non‐cancer pain

  2007cited by this paper
• Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction

  2007cited by this paper
• Major increases in opioid analgesic abuse in the United States: concerns and strategies.

  2006cited by this paper
• Measuring diagnoses: ICD code accuracy.

  2005cited by this paper
• Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders.

  2003cited by this paper
• College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

  2003cited by this paper
• The use of propensity scores in pharmacoepidemiologic research

  2000cited by this paper
• Clarification and standardization of substance abuse terminology.

  1988cited by this paper

• Comparative risk of delirium among opioid users for non-cancer pain: a retrospective cohort study

  2026cites this paper
• Evidence-based framework for identifying opioid use disorder in administrative data: A systematic review and methodological development study

  2025cites this paper
• Hormonal and Histological Changes in the Ovaries of Wistar Rats Treated with Oxycodone Hydrochloride

  2025cites this paper
• Potential roles for vitamin D in preventing and treating impulse control disorders, behavioral addictions, and substance use disorders: A scoping review

  2024cites this paper
• Wastewater-based evaluation of the efficacy of oxycodone regulations in Australia.

  2024cites this paper
• Analysis of Opioid-Related Adverse Events in Japan Using FAERS Database

  2023cites this paper
• Superficial heat in the treatment of non-specific low back and neck pain (literature review)

  2023cites this paper
• Pyrimidine nucleotides in pain management. Consensus of the international group of specialists

  2023cites this paper
• Assessing the risks of abuse of opioids in real-world data

  2023cites this paper
• Opioid Dependence and Associated Health Care Utilization and Cost in Traumatic Spinal Cord Injury Population: Analysis Using Marketscan Database.

  2023cites this paper
• Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving

  2023cites this paper
• Risk factors for the development of opioid use disorder after first opioid prescription: a Swedish national study

  2022cites this paper
• Characteristics of fatal tapentadol-related toxicity in Australia.

  2022cites this paper
• Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review

  2022cites this paper
• Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

  2022cites this paper
• Preoperative and Postoperative Opioid Dependence in Patients Undergoing Anterior Cervical Diskectomy and Fusion for Degenerative Spinal Disorders

  2021cites this paper
• Defining "Doctor shopping" with Dispensing Data: A Scoping Review.

  2021cites this paper
• Nitric oxide modulates tapentadol antinociceptive tolerance and physical dependence.

  2021cites this paper
• Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: Evidence and opportunities.

  2021cites this paper
• Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States

  2020cites this paper
• Perioperative Serum 25-Hydroxyvitamin D Levels as a Predictor of Postoperative Opioid Use and Opioid Use Disorder: a Cohort Study

  2020cites this paper
• The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials

  2020cites this paper
• Risk Factors for Misuse of Prescribed Opioids: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Новый опиоидный анальгетик тапентадол в терапии нейропатической боли в онкологии

  2019cites this paper
• Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.

  2019cites this paper
• Characterizing the experience of tapentadol non-medical use: an online forum survey and interactive chat (Preprint)

  2019cites this paper
• Opioid Dependence and Health Care Utilization After Decompression and Fusion in Patients With Adult Degenerative Scoliosis

  2019cites this paper
• A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section

  2019cites this paper
• Oxycodone’s Unparalleled Addictive Potential: Is it Time for a Moratorium?

  2019cites this paper
• New opioid analgesic tapentadol in the treatment of neuropathic pain in oncology

  2019cites this paper
• Factors predicting opioid dependence in patients undergoing surgery for degenerative spondylolisthesis: analysis from the MarketScan databases.

  2018cites this paper
• Comparative pharmacology and toxicology of tramadol and tapentadol

  2018cites this paper
• Opioid Abuse or Dependence Increases 30-day Readmission Rates after Major Operating Room Procedures: A National Readmissions Database Study

  2018cites this paper
• Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol

  2018cites this paper
• Health care utilization and overall costs based on opioid dependence in patients undergoing surgery for degenerative spondylolisthesis.

  2018cites this paper
• Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta‐analysis

  2018cites this paper
• Comorbid opioid dependence and chronic pain : clinical implications

  2018cites this paper
• Tapentadol, un nuevo horizonte en el tratamiento de la neuropatía diabética periférica dolorosa

  2018cites this paper
• Mechanistic evaluation of tapentadol in reducing the pain perception using in‐vivo brain and spinal cord microdialysis in rats

  2017cites this paper
• Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.

  2017cites this paper
• An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers

  2017cites this paper
• Perspectives on Intravenous Oxycodone for Control of Postoperative Pain

  2016cites this paper
• Use of Opioids in Latin America: The Need of an Evidence-Based Change.

  2016cites this paper
• Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?

  2016cites this paper
• Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review

  2016cites this paper
• Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability

  2016cites this paper
• Worldwide research productivity on tramadol: a bibliometric analysis

  2016cites this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION

  2016cites this paper
• Usos terapéuticos potenciales de los antagonistas opioides: Fisiopatología y evidencia preclínica

  2015cites this paper
• Opiacés dits forts dans les pathologies non cancéreuses de l’appareil locomoteur : pas plus efficaces que le paracétamol ou les AINS

  2015cites this paper
• Structure activity studies of an analgesic drug tapentadol hydrochloride by spectroscopic and quantum chemical methods

  2015cites this paper
• Chapter 8 - Opioid Analgesics and Narcotic Antagonists

  2015cites this paper
• Tapentadol and Dual Pain Inhibition: A New Strategy for Pain Relief in Australia

  2015cites this paper
• Feasibility and utility of applications of the common data model to multiple, disparate observational health databases

  2015cites this paper
• Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs.

  2015cites this paper
• Oxygen therapy and anaesthesia: too much of a good thing?

  2015cites this paper
• Tapentadol extended release in the management of peripheral diabetic neuropathic pain

  2015cites this paper
• Tapentadol ‐ the evidence so far

  2015cites this paper
• The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.

  2015cites this paper
• literature used to formulate policy decisions and improve healthcare for Americans

  2014cites this paper
• Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse

  2014cites this paper
• Perioperative analgesia: ever-changing technology and pharmacology.

  2014cites this paper
• Recent advances in the pharmacological management of acute and chronic pain.

  2014cites this paper
• The US FDA Draft Guidance for Developing Abuse-Deterrent Opioid Analgesics: 2014 and Beyond

  2014cites this paper
• Abbreviated Bibliography Since 1988 , healthcare researchers have used Truven Health MarketScan

  2012cites this paper